Michael Soormann
Chairman at RWD Group Reppisch Wer AG
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michael Pieper | M | 78 |
RWD Group Reppisch Wer AG
| - |
| Heinz Loosli | M | 70 | 15 years | |
| Oliver Wiedow | M | 66 |
University of Kiel
| 39 years |
| Norbert Indlekofer | M | 66 | 6 years | |
| Felix Suter | M | - |
Hello AG
| - |
| Marcus Bollig | M | 57 | 4 years |
See more
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Armin Bolz | M | 59 |
Friedrich-Alexander University of Erlangen-Nuremberg
| 8 years |
| António Jorge Viegas de Vasconcelos | M | - |
Friedrich-Alexander University of Erlangen-Nuremberg
| 3 years |
| Peter Wilden | M | 67 |
University of Kiel
| 6 years |
| Mat Hartz | M | - | 3 years | |
| Gerhard Schmidt | M | 67 |
Friedrich-Alexander University of Erlangen-Nuremberg
| 5 years |
| Rolf Ernst | M | - |
Friedrich-Alexander University of Erlangen-Nuremberg
| 8 years |
| Wolfgang Feil | M | 80 | 14 years | |
| Adrian Widmer | M | 56 |
Degussa Construction Chemicals Schweiz AG
| 7 years |
| Jörg Ernst Franke | M | 60 |
Friedrich-Alexander University of Erlangen-Nuremberg
| 12 years |
| Maximilian A. Biberger | M | - |
Friedrich-Alexander University of Erlangen-Nuremberg
| 3 years |
| Michael Bettag | M | 62 |
Friedrich-Alexander University of Erlangen-Nuremberg
| 4 years |
| Simone Menne | F | 63 |
University of Kiel
| 5 years |
| Niels Pörksen | M | 60 |
University of Kiel
| 4 years |
| Thomas Stockmeier | M | 65 |
Friedrich-Alexander University of Erlangen-Nuremberg
| 4 years |
| Bernhard Geisen | M | - | 6 years | |
| Knut Zimmer | M | 61 | 4 years | |
| Steffen Schroth | M | 66 | 2 years | |
| Othmar Zenker | M | 61 |
University of Kiel
| 4 years |
| Maria Founti | F | 69 |
Friedrich-Alexander University of Erlangen-Nuremberg
| 4 years |
| Hans-Peter Bartels | M | 62 |
University of Kiel
| 1 years |
| Klaus Ernst Zimmermann | M | 67 |
Friedrich-Alexander University of Erlangen-Nuremberg
| 4 years |
| Bruno Malinek | M | - | 2 years | |
| Christophe Biollaz | M | 56 |
Sandoz AG
 Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The company is based in Basel, Switzerland. | - |
| Matthias Baumann | M | - |
Friedrich-Alexander University of Erlangen-Nuremberg
| 3 years |
| Wojciech Kostrzewa | M | 64 |
University of Kiel
| 4 years |
| Stephan Prebeck | M | - | 5 years | |
| Bruno Edelmann | M | 58 | 9 years | |
| Thomas A. Lange | M | 61 |
University of Kiel
| 3 years |
| Birge Bargmann | F | 62 |
University of Kiel
| 18 years |
| Olaf Hein | M | 66 |
University of Kiel
| 4 years |
| Gerd Peter Poppinga | M | 64 |
Friedrich-Alexander University of Erlangen-Nuremberg
| 1 years |
| Werner Brandt | M | 70 |
Friedrich-Alexander University of Erlangen-Nuremberg
| 5 years |
| Wolfgang Colberg | M | 64 |
University of Kiel
| 3 years |
| Andreas Rummelt | M | 67 |
Friedrich-Alexander University of Erlangen-Nuremberg
| 3 years |
| Walter Raizner | M | 70 |
Friedrich-Alexander University of Erlangen-Nuremberg
| 4 years |
| Thomas A. Erb | M | 79 | 8 years | |
| Jost Massenberg | M | 67 |
University of Kiel
| 3 years |
| Manfred F. Schlapps | M | - |
Friedrich-Alexander University of Erlangen-Nuremberg
| 4 years |
| Ingrid Hamm | M | - |
Friedrich-Alexander University of Erlangen-Nuremberg
| 3 years |
| Fritz Kunz | M | - |
Sandoz AG
Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The company is based in Basel, Switzerland. | 21 years |
| Thomas Muhr | M | 61 | 4 years | |
| Kurt E. Stirnemann | M | 81 | 9 years | |
| Rolf-Dieter Kempis | M | 71 | 2 years | |
| Frank Westhoff | M | 63 |
Friedrich-Alexander University of Erlangen-Nuremberg
| 6 years |
| Hermann Orth | M | 72 |
Friedrich-Alexander University of Erlangen-Nuremberg
| 3 years |
| Victor A. Bischoff | M | 77 |
Sandoz AG
Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The company is based in Basel, Switzerland. | 6 years |
| Monika Löffel-Bösch | F | 64 | 16 years | |
| Andreas Mohnberg | M | 62 |
University of Kiel
| 4 years |
| Arthur Locher | M | 79 | 6 years | |
| Thomas Sprock | M | - |
University of Kiel
| 2 years |
| Christian Mäder | M | 55 | - | |
| Thomas Haeberle | M | 68 |
Friedrich-Alexander University of Erlangen-Nuremberg
| 7 years |
| Thomas Faiq Dressendörfer | M | 66 |
Friedrich-Alexander University of Erlangen-Nuremberg
| 1 years |
| Frank Mielke | M | - |
University of Kiel
| 4 years |
| Stephan Götzl | M | 64 |
Friedrich-Alexander University of Erlangen-Nuremberg
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Germany | 37 | 60.66% |
| Switzerland | 24 | 39.34% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Michael Soormann
- Personal Network
